Component

Ghrelin

Species, exposure, manipulation and limitations are specified on each linked claim.

3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

Where it participates (unsigned role)

  1. Compared with the control cereal, 4 grams of oat beta-glucan significantly reduced glucose incremental area under the curve at 78 compared with 135 mmol x min/L and insulin at 14.0 compared with 26.8 nmol x min/L and delayed gastric emptying half-time to a geometric mean of 285 minutes compared with 105 minutes, effects not seen after the beta-glucanase-treated arm of the same dose, while subjective appetite, PYY and ghrelin responses were similar to control and pizza intakes at a subsequent unrestricted meal were not significantly different.

    Experimental context and source evidence
    availability_state
    biomarker_context Imported condition classification; unverified.
    evidence_span
    {"source_cache": "artifacts/glucan-research/31828287.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "983ae8675d933c4292f9f20059e93db94587b9a570fbfb602f5921f5bd7edd70", "start_char": 0, "end_char": 2204, "text_sha256": "983ae8675d933c4292f9f20059e93db94587b9a570fbfb602f5921f5bd7edd70"}
    experimental_model
    Double-blind randomised crossover trial in 28 participants with gastric emptying, appetite hormones and an unrestricted test lunch
    exposure
    Breakfast meals matched for weight, energy and macronutrients containing 2 or 4 grams of oat beta-glucan, or 4 grams treated with beta-glucanase to reduce molecular weight and viscosity
    limitations
    The beta-glucanase arm is the control that isolates viscosity. The trial was designed around food intake as the primary endpoint and found no effect on it.
    nutrient_topic
    Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. · Beta-glucan
    organism
    Human
    plain_language
    The intact polymer held the meal in the stomach nearly three times longer; the same dose chopped up did nothing.
    primary_references
    [bg-p31828287] Increasing oat β-glucan viscosity in a breakfast meal slows gastric emptying and reduces glycemic and insulinemic responses but has no effect on appetite, food intake, or plasma ghrelin and PYY responses in healthy humans: a randomized, placebo-controlled, crossover trial. (2020). https://pubmed.ncbi.nlm.nih.gov/31828287/ DOI: 10.1093/ajcn/nqz285
    tissue_or_cell_type
    Stomach and postprandial circulation
    trigger_kind
    biomarker_context Imported condition classification; unverified.

    Beta-glucan: a structural family rather than an agent, what decides whether a bound glucan actually signals, the complement route that a cereal and a yeast preparation share, and the unequal human evidence behind each (2026-09-22) · lines 580–591

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind randomised crossover trial in 28 participants with gastric emptying, appetite hormones and an unrestricted test lunch · source_derived_draft · unverified_draft

    ### bg-viscosity-slows-the-stomach Compared with the control cereal, 4 grams of oat beta-glucan significantly reduced glucose incremental area under the curve at 78 compared with 135 mmol x min/L and insulin at 14.0 compared with 26.8 nmol x min/L and delayed gastric emptying half-time to a geometric mean of 285 minutes compared with 105 minutes, effects not seen after the beta-glucanase-treated arm of the same dose, while subjective appetite, PYY and ghrelin responses were similar to control and pizza intakes at a subsequent unrestricted meal were not significantly different. Condition category: biomarker_context nutrient_topic: Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. plain_language: The intact polymer held the meal in the stomach nearly three times longer; the same dose chopped up did nothing. organism: Human tissue_or_cell_type: Stomach and postprandial circulation experimental_model: Double-blind randomised crossover trial in 28 participants with gastric emptying, appetite hormones and an unrestricted test lunch limitations: The beta-glucanase arm is the control that isolates viscosity. The trial was designed around food intake as the primary endpoint and found no effect on it. exposure: Breakfast meals matched for weight, energy and macronutrients containing 2 or 4 grams of oat beta-glucan, or 4 grams treated with beta-glucanase to reduce molecular weight and viscosity evidence_span: {"source_cache": "artifacts/glucan-research/31828287.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "983ae8675d933c4292f9f20059e93db94587b9a570fbfb602f5921f5bd7edd70", "start_char": 0, "end_char": 2204, "text_sha256": "983ae8675d933c4292f9f20059e93db94587b9a570fbfb602f5921f5bd7edd70"} [bg-p31828287] Increasing oat β-glucan viscosity in a breakfast meal slows gastric emptying and reduces glycemic and insulinemic responses but has no effect on appetite, food intake, or plasma ghrelin and PYY responses in healthy humans: a randomized, placebo-controlled, crossover trial. (2020). https://pubmed.ncbi.nlm.nih.gov/31828287/ DOI: 10.1093/ajcn/nqz285
    Complete structured claim and evidence
  2. Inulin but not resistant starch significantly increased the short-chain fatty acid area under the curve from 4 to 6 hours, yet neither affected the GLP-1 or PYY area under the curve, while ghrelin at 6 hours after inulin was significantly lower than after glucose and the change in short-chain fatty acid area was negatively related to the change in ghrelin area; responses did not differ significantly between lean and overweight subjects.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/acetate-research/27966574.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c0282e2d96baff8a6dde713af91c9df8641d7075c78cf1453ee7d74f6016cd3", "start_char": 0, "end_char": 1724, "text_sha256": "7c0282e2d96baff8a6dde713af91c9df8641d7075c78cf1453ee7d74f6016cd3"}
    experimental_model
    Randomised single-blind crossover in 13 overweight or obese and 12 lean humans
    exposure
    75 g glucose alone, or with 24 g inulin or 28.2 g resistant starch, with blood sampled over 6 hours
    limitations
    The ligand did rise: inulin significantly increased the 4 to 6 hour short-chain fatty acid area under the curve. The authors note that a longer adaptation or a larger sample might give a different answer.
    nutrient_topic
    Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. · Acetic acid
    organism
    Human
    plain_language
    In people the fatty acids rose and the two appetite hormones did not move, though ghrelin fell.
    primary_references
    [acetate-p27966574] Acute increases in serum colonic short-chain fatty acids elicited by inulin do not increase GLP-1 or PYY responses but may reduce ghrelin in lean and overweight humans. (2017). https://pubmed.ncbi.nlm.nih.gov/27966574/ DOI: 10.1038/ejcn.2016.249
    tissue_or_cell_type
    Whole body

    Acetic acid: the ingested acid, the receptors acetate binds, the acetyl-CoA it becomes, and the acetyl groups that reach histones (2026-09-21) · lines 368–379

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomised single-blind crossover in 13 overweight or obese and 12 lean humans · source_derived_draft · unverified_draft

    ### acetate-no-human-glp1 Inulin but not resistant starch significantly increased the short-chain fatty acid area under the curve from 4 to 6 hours, yet neither affected the GLP-1 or PYY area under the curve, while ghrelin at 6 hours after inulin was significantly lower than after glucose and the change in short-chain fatty acid area was negatively related to the change in ghrelin area; responses did not differ significantly between lean and overweight subjects. Condition category: normal nutrient_topic: Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. plain_language: In people the fatty acids rose and the two appetite hormones did not move, though ghrelin fell. organism: Human tissue_or_cell_type: Whole body experimental_model: Randomised single-blind crossover in 13 overweight or obese and 12 lean humans limitations: The ligand did rise: inulin significantly increased the 4 to 6 hour short-chain fatty acid area under the curve. The authors note that a longer adaptation or a larger sample might give a different answer. exposure: 75 g glucose alone, or with 24 g inulin or 28.2 g resistant starch, with blood sampled over 6 hours evidence_span: {"source_cache": "artifacts/acetate-research/27966574.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c0282e2d96baff8a6dde713af91c9df8641d7075c78cf1453ee7d74f6016cd3", "start_char": 0, "end_char": 1724, "text_sha256": "7c0282e2d96baff8a6dde713af91c9df8641d7075c78cf1453ee7d74f6016cd3"} [acetate-p27966574] Acute increases in serum colonic short-chain fatty acids elicited by inulin do not increase GLP-1 or PYY responses but may reduce ghrelin in lean and overweight humans. (2017). https://pubmed.ncbi.nlm.nih.gov/27966574/ DOI: 10.1038/ejcn.2016.249
    Complete structured claim and evidence
  3. Adding lactisole to sucrose did not significantly change postprandial plasma ghrelin.

    Lactisole → Human postprandial plasma ghrelin response source_derived_draftungraded
    Experimental context and source evidence
    dose
    300 mL of 10% w/v sucrose with or without 60 ppm lactisole; parallel glucose conditions
    duration
    120 minutes; breakfast at 2 hours
    evidence_access
    Primary full-text methods/results and metadata inspected.
    evidence_scope
    literature_reviewed; source-specific curation
    experimental_model
    27 healthy men in randomized single-blinded crossover
    exposure_scope
    Sucrose and taste antagonist
    limitations
    Acute experiment in men; peripheral serotonin is not brain serotonin. Receptor mediation and binding-affinity explanation were not directly established; no long-term weight outcome.
    nutrient_topic
    Sucrose chapter; direct sucrose observations are distinguished from shared component metabolism. · Sucrose
    organism
    27 healthy men in randomized single-blinded crossover
    plain_language
    Adding lactisole to sucrose did not significantly change postprandial plasma ghrelin.
    primary_references
    Sweet Taste Antagonist Lactisole Administered in Combination with Sucrose, But Not Glucose, Increases Energy Intake and Decreases Peripheral Serotonin in Male Subjects. (2020). https://pubmed.ncbi.nlm.nih.gov/33066498/ DOI: 10.3390/nu12103133
    route
    Oral test drink after overnight fast
    tissue
    Subsequent food intake and peripheral hormone measurements

    Sucrose: mechanism of action and metabolic impact (2026-09-20) · lines 151–161

    Original AI-assisted source-specific sucrose curation with shared canonical claims retained by identity. Primary-study citations, negative findings, exposure details and limitations preserved. Not publisher full text. · supports · 27 healthy men in randomized single-blinded crossover · source_derived_draft · unverified_draft

    ## sucrose-lactisole-ghrelin-null Adding lactisole to sucrose did not significantly change postprandial plasma ghrelin. Model/species: 27 healthy men in randomized single-blinded crossover Tissue: Subsequent food intake and peripheral hormone measurements Exposure: 300 mL of 10% w/v sucrose with or without 60 ppm lactisole; parallel glucose conditions Route: Oral test drink after overnight fast Duration: 120 minutes; breakfast at 2 hours Exposure scope: Sucrose and taste antagonist Limits: Acute experiment in men; peripheral serotonin is not brain serotonin. Receptor mediation and binding-affinity explanation were not directly established; no long-term weight outcome. Reference: Sweet Taste Antagonist Lactisole Administered in Combination with Sucrose, But Not Glucose, Increases Energy Intake and Decreases Peripheral Serotonin in Male Subjects. (2020). https://pubmed.ncbi.nlm.nih.gov/33066498/ DOI: 10.3390/nu12103133 Access: Primary full-text methods/results and metadata inspected.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards